BTW, DOWNLOAD part of Prep4sureGuide ALS-Con-201 dumps from Cloud Storage: https://drive.google.com/open?id=19yYydYpPj3XqvchvDOZZLBgvBtUyH7-S
We have professional technicians to check the website at times, therefore we can provide you with a clean and safe shopping environment if you buy ALS-Con-201 training materials. In addition, we have free demo for you before purchasing, so that you can have a better understanding of what you are going to buying. Free update for 365 days is available, and you can get the latest information for the ALS-Con-201 Exam Dumps without spending extra money. We have online and offline chat service stuff, and they possess the professional knowledge for the ALS-Con-201 training materials, if you have any questions, just contact us.
| Topic | Details |
|---|---|
| Topic 1 |
|
| Topic 2 |
|
| Topic 3 |
|
| Topic 4 |
|
>> Reliable Salesforce ALS-Con-201 Test Sims <<
Passing the ALS-Con-201 exam has never been so efficient or easy when getting help from our ALS-Con-201 training materials. This way is not only financially accessible, but time-saving and comprehensive to deal with the important questions emerging in the real exam. All exams from different suppliers will be easy to handle. Actually, this ALS-Con-201 Exam is not only practical for working or studying conditions, but a manifest and prestigious show of your personal ability.
NEW QUESTION # 102
Choose 1 option.
Cumulus Pharma uses Agentforce Life Sciences for Customer Engagement to provide Account Summaries. The Agentforce Life Sciences Consultant configured a Cross-Object Field History Graph to include related Provider Visit and Medical Inquiry records. Key Account Managers report that summaries include all related data; however, field sales reps report that their summaries exclude visit and inquiry data. Both user groups have Read access to the underlying objects.
What is the cause of this issue?
Answer: B
Explanation:
The correct answer is A because Account Summarization can use different Cross-Object Field History Graph assignments by org or profile. Salesforce Help for Life Sciences Account Summarization states that administrators can create a Cross-Object Graph for Account Summarization and assign cross-object graphs to an org or profile. Salesforce also describes the Account Summarization workflow as using configured cross-object field history so summaries can include recent and relevant account changes from related objects.
In this case, KAMs see summaries that include Provider Visit and Medical Inquiry records, while field sales reps do not. Both groups have Read access to the objects, so object permission is not the root cause. The difference is most likely profile-based summarization configuration: the graph containing Provider Visit and Medical Inquiry data has been assigned to the KAM profile but not to the field sales rep profile.
Option B is incorrect because Account Summary generation in this scenario is driven by Cross-Object Field History Graph configuration, not membership in a Data 360 segment. Option C is also incorrect because the question explicitly says both user groups have Read access. View All is not the stated requirement for using a graph in summarization. Therefore, the issue is that the Cross-Object Field History Graph is not assigned to the field sales rep profile.
=========
NEW QUESTION # 103
Choose 1 option.
An Agentforce Life Sciences Consultant configured the Inquiry record page to provide a comprehensive history view. Users need to see a chronological list of all key events and changes associated with the inquiry.
Which step must the consultant take to expose this historical data on the Lightning record page?
Answer: C
Explanation:
Option A is correct because Salesforce Help for setting up the Inquiry record page for Medical Inquiries explicitly states that, to view timeline details for inquiries, the consultant should drag the Timeline component to the page. The requirement in the question is to expose a chronological list of key events and changes associated with the inquiry. That is exactly the purpose of the Timeline component on the Medical Inquiries record page.
Salesforce also documents Enhanced Timeline for Life Sciences Cloud, explaining that the Enhanced Timeline component shows key events relating to a person or a record. This supports the use case of giving users a consolidated, chronological view of relevant inquiry activity, rather than requiring them to inspect multiple related lists or audit records separately.
Option B is not the best answer because field history tracking and the standard History component are used for field-level audit history, not the Life Sciences Medical Inquiries timeline experience. Option C is also incorrect because adding an Inquiry History related list would expose related records, but it would not provide the configured timeline component experience described in Salesforce's Medical Inquiries setup documentation.
Therefore, the consultant must drag the Timeline component onto the Lightning record page and configure its component details for the Inquiry record page.
NEW QUESTION # 104
Choose 1 option.
A field sales rep is ready to capture a Healthcare Provider's (HCP's) signature on an iPad for a sample drop-off. For Food and Drug Administration (FDA) 21 CFR Part 11 compliance, the system must capture the image of the signature and create a non-editable audit trail linking the signature to the specific samples and timestamp.
Which Agentforce Life Sciences for Customer Engagement feature should an Agentforce Life Sciences Consultant enable to support this rigorous audit requirement?
Answer: A
Explanation:
The correct answer is C because Salesforce's electronic signature capability for Life Sciences is Digital Verification. Salesforce Help states that the Electronic Signature feature provides 21 CFR Part 11-ready electronic signature functionality, and the setup guidance directs administrators to configure the Digital Verifications feature to manage electronic signatures in Salesforce rather than relying on a third-party application.
The requirement is specific to regulated sample drop-off. The system must capture the HCP's signature image, associate it with the sample disbursement, preserve the timestamp, and maintain an audit trail that supports compliance expectations. Digital Verification is the Salesforce Life Sciences feature designed to support electronic-signature capture in this type of regulated workflow.
Option A, Shield Audit Trail, is incorrect because Salesforce Shield can help with broader platform security, event monitoring, and auditability, but it is not the Life Sciences feature that captures an HCP's electronic signature for sample drop-off. Option B, DocuSign for Salesforce, is also incorrect because the question asks for the Agentforce Life Sciences for Customer Engagement feature that supports this requirement. Salesforce Help specifically points to Digital Verification for managing electronic signatures directly in Salesforce. Therefore, the consultant should enable Digital Verification to support the 21 CFR Part 11-ready signature and audit requirements.
=========
NEW QUESTION # 105
Choose 1 option.
Cumulus Pharma's director of compliance requires its field sales reps to verify current sample holdings against the digital audit trail to prepare for an upcoming Food and Drug Administration (FDA) inspection.
Which assessment type meets this requirement?
Answer: B
Explanation:
The correct answer is B because the requirement is specifically compliance-driven verification of sample holdings against an audit trail. Salesforce Help for Sample Inventory Management identifies inventory assessment types, including Ad hoc, Periodic, and Audited. It describes Ad hoc as an unplanned inventory count, Periodic as an inventory count used to comply with organizational guidelines, and Audited as a self-audit, declaration of inventory count, or peer audit.
The scenario mentions preparation for an FDA inspection, which is more rigorous than a routine count or unplanned check. The purpose is to verify current holdings against the digital audit trail and support compliance evidence. An Audited assessment is designed for this type of controlled verification because it supports audit-oriented sample inventory confirmation.
Option A, Ad Hoc, is incorrect because an ad hoc count is generally unplanned and operational, such as preparing for a visit or checking inventory outside a regular schedule. While useful, it does not best represent formal inspection readiness. Option C, Periodic, is also not the best answer because periodic counts are recurring counts based on company policy or schedule. The question focuses on audit preparation and verification against the digital audit trail, making Audited the most appropriate assessment type. Therefore, the consultant should recommend an Audited assessment.
=========
NEW QUESTION # 106
Choose 1 option.
Cumulus Pharma has a compliance policy regarding "Off-Label" discussions. The company's Agentforce Life Sciences Consultant needs to configure the Agentforce Life Sciences visit experience to explicitly control whether field sales reps are allowed to discuss products for indications that have not yet been approved.
Which setting within the Admin Console handles this capability?
Answer: B
Explanation:
The correct answer is B because off-label control in the visit experience is tied to product detailing behavior. In life sciences commercial engagement, product detailing governs what products, messages, indications, and approved content can be discussed or shown during a visit. Salesforce Trailhead describes Life Sciences Cloud content visibility as being filtered by territory, product assignment, and account restrictions to prevent off-label or noncompliant sharing. This aligns most closely with Visit Settings > Product Detailing Settings, because that is the visit configuration area where product discussion and detailing behavior is controlled.
The question asks where the consultant should configure whether reps are allowed to discuss products for unapproved indications. That is not a generic compliance switch; it is a visit-detailing control connected to product and indication behavior in the field engagement workflow. Product Detailing Settings are therefore the correct place to enforce whether off-label discussion is permitted, warned, or restricted according to company policy.
Option A is incorrect because "Compliance Settings > Off-Label Validation" is not the standard configuration path presented in the available options for the Life Sciences visit experience. Option C is also incorrect because Restricted Products would control whether products are available or restricted, but the scenario is specifically about discussion of unapproved indications during product detailing. Therefore, the consultant should use Visit Settings > Product Detailing Settings.
=========
NEW QUESTION # 107
......
Prep4sureGuide is professional platform to establish for compiling ALS-Con-201 exam materials for candidates, and we aim to help you to pass the examination as well as getting the related certification in a more efficient and easier way. Owing to the superior quality and reasonable price of our ALS-Con-201 Exam Materials, our ALS-Con-201 exam torrents are not only superior in price than other makers in the international field, but also are distinctly superior in many respects.
ALS-Con-201 Lab Questions: https://www.prep4sureguide.com/ALS-Con-201-prep4sure-exam-guide.html
DOWNLOAD the newest Prep4sureGuide ALS-Con-201 PDF dumps from Cloud Storage for free: https://drive.google.com/open?id=19yYydYpPj3XqvchvDOZZLBgvBtUyH7-S